Peer-influenced content. Sources you trust. No registration required. This is HCN.
MDLinx
You could have a patient with an LDL-C of 100 mg/dL and think they’re in the clear, but if their LDL-P is sky-high, they’re still at risk for plaque formation.
Cardiology April 8th 2025
Journal of the American College of Cardiology (JACC)
Community-based centers with limited resources should identify an on-site clinician to serve as their ‘shock champion’ as well as a center providing advanced heart failure therapies to partner with on complex CS cases.
Patients with ACS are at the highest risk for cardiovascular complications both acutely and chronically, which emphasizes the importance of staying up-to-date on the most recent evidence presented in this guideline.
Cardiology March 11th 2025
Medical News Today (MNT)
In terms of overall survival rates, the tricaprin group had 100% three-year and five-year survival rates. In contrast, the control group had a 78.6% three-year survival rate and a 68.1% five-year survival rate.
Journal of Invasive Cardiology (JIC)
A fixed 5000 IU heparin dose achieved consistent RAO prevention across all weight groups, with rates ranging from 1.9% to 3.0%, suggesting potential benefits of standardized protocols.
Cardiology February 10th 2025
EP – Europace
In this 22-center study of repeat ablations following PFA, 45% of patients maintained complete pulmonary vein isolation from their initial procedure, with subsequent success rates varying significantly by arrhythmia type.